All public logs

Combined display of all available logs of Beacon. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

14:18, 24 June 2024 Victor talk contribs deleted page National Institute of Oncology Trials (content was: "'''NCTID''': NCT05169567 '''Title''': Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer '''Study Summary''': This study will evaluate the effect of adding abemaciclib to fulvestrant for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer tha...", and the only contributor was "Woloski" (talk))
14:18, 24 June 2024 Victor talk contribs deleted page National Cancer Institute Trials (content was: "'''NCTID''': NCT03425643 '''Title''': Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) '''Study Summary''': This trial will evaluate the safety and efficacy of pembrolizumab (MK-3...", and the only contributor was "Woloski" (talk))
14:18, 24 June 2024 Victor talk contribs deleted page National Cancer Center Dresden Trials (content was: "'''NCTID''': NCT03430843 '''Title''': A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma '''Study Summary''': The purpose of this study is to evaluate the efficacy and safety of tislelizumab as second line treatment in participants with advanced unresectable/metastatic ESCC that h...", and the only contributor was "Woloski" (talk))
14:18, 24 June 2024 Victor talk contribs deleted page Motol University Hospital Trials (content was: "{{forpatients}} {{forresearchers}} Go back to Motol University Hospital page '''NCTID''': NCT02447666 '''Title''': Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) '''Study Summary''': Indication Treatment of pediatric subjects with newly diagnosed advanced myelodysplastic syndrome (MDS) or juvenile myelomonocytic leukemia (JMML) prior to hematopoietic stem cell transpl...")
14:14, 24 June 2024 Victor talk contribs created page Beacon:About (Created page with "You can read about our methodology for collecting data here: Methodology.")
13:48, 24 June 2024 Victor talk contribs deleted page Mediterranean Institute of Oncology Trials (content was: "'''NCTID''': NCT06008691 '''Title''': A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice '''Study Summary''': This is a prospective, observational cohort study to evaluate the clinical impact of novel Monoclonal AntiBodies (MAB) in B-cell Non-Hodgkin Lymphoma (NHL) in I...", and the only contributor was "Woloski" (talk))
13:48, 24 June 2024 Victor talk contribs deleted page Masaryk Memorial Cancer Institute Trials (content was: "'''NCTID''': NCT05603351 '''Title''': Prostate Cancer Screening With Abbreviated MRI Protocol '''Study Summary''': Prostate cancer is one of the most common malignancies in the male population with incidence and mortality rates comparable to breast cancer in women, but in contrast, a population screening program that would fulfill all the recommended criteria is not yet avai...", and the only contributor was "Woloski" (talk))
13:48, 24 June 2024 Victor talk contribs deleted page Maria Sklodowska- Curie National Research Institute of Oncology Trials (content was: "'''NCTID''': NCT03517137 '''Title''': Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study '''Study Summary''': The main objective of this trial is to assess whether treatment adaptation based on a very early FDG-PET/CT results in improved efficacy while minimizing treatment toxicity in advanced stage Hodgkin Lymphoma...", and the only contributor was "Woloski" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Léon Bérard Center Trials (content was: "'''NCTID''': NCT01222767 '''Title''': Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy '''Study Summary''': This is a phase II Multicenter, Open-label, Clinical and Pharmacokinetic Study of Zalypsis® (PM00104) in Patients with Unresectable L...", and the only contributor was "Woloski" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Lymphoma Association Flanders (Belgium) (content was: "Go back to Belgium page {{forpatients}} '''Primary purpose:''' To support and advocate for lymphoma patients and their families while promoting awareness and improving the overall care and well-being of those affected by the disease. '''Contact information:''' Information [https://www.lymfklierkanker.be/nl/contactformulier].", and the only contributor was "Francine" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Learning Resources (Kortrijk Cancer Centre AZ Groeninge) (content was: "=== Trainings: Symposia and Training === '''Primary purpose:''' To offer symposia and training opportunities tailored to various healthcare professionals. '''Target audience:''' Doctors, general practitioners, physiotherapists and related professionals. '''Access Information:''' Information [https://www.azgroeninge.be/nl/professionals/symposia-en-opleidingen]. === Event...", and the only contributor was "Francine" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Learning Resources (Brussels Cancer Centre - Centre du Cancer Bruxelles) (content was: "=== Training: Internship === '''Content type:''' Provide training on different areas of care, including oncology, under the supervision of experts. '''Target audience:''' Nurses, paramedics and psicologists. '''Access:''' Registration [https://www.uzbrusselwerkt.be/onze-vacatures/stagiairs].", and the only contributor was "Francine" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Learning Resources (content was: "'''[This page is empty. Information will be added soon.]'''", and the only contributor was "Lucas" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Latest Policymaking Initiatives (content was: "'''[This page is empty. Information will be added soon.]'''", and the only contributor was "Lucas" (talk))
13:47, 24 June 2024 Victor talk contribs deleted page Cancer Areas of Interest: Bulgarian National Cancer Registry (content was: "Go back to Bulgaria page Source: [https://sbaloncology.bg/index.php/bg/%D1%81%D1%82%D1%80%D1%83%D0%BA%D1%82%D1%83%D1%80%D0%B0/%D0%BD%D0%B0%D1%86%D0%B8%D0%BE%D0%BD%D0%B0%D0%BB%D0%B5%D0%BD-%D1%80%D0%B0%D0%BA%D0%BE%D0%B2-%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%8A%D1%80/42-%D1%81%D1%82%D1%80%D1%83%D0%BA%D1%82%D1%83%D1%80%D0%B0/%D0%BD%D0%B0%D1%86%D0%B8%D0%BE%D0%BD%D0%B0%D0%BB%D0%B5%D0%BD-%D1%80%D0%B0%D0%BA%D0%BE%D0%B2-%D1%80%D0%B5%D0%B3%D0%B8%D1%81%D1%82%D1%8A%D1%80/365-%D0%BE%...")
13:44, 24 June 2024 Victor talk contribs deleted page Database: National Cancer Registry (Bulgaria) (content was: "{{forresearchers}} Go back to Bulgaria page '''Primary purpose:''' Systematic collection, storage, organization, analysis, interpretation, publication and protection of data for persons with malignant neoplasms and carcinoma in situ throughout the country. '''Sponsor, manager or home institution:''' dataOwner::Bulgarian National Cancer Registry. '''Type of information:''' Data dictionary was not found. '''Available type of information:''' availableVariable::cancer...")
13:44, 24 June 2024 Victor talk contribs deleted page Database: Cancer Survival and Incidence in the Northern Region of Portugal (Portugal) (content was: "Go back to Portugal page {{forresearchers}} '''Primary purpose:''' Inform about cancer statistics regarding the south region of Portugal. Gathers information about the following districts: Braga, Bragança, Porto, Viana do Castelo and Vila Real. '''Sponsor, manager or home institution''': dataOwner::National Cancer Registry (RON) and dataOwner::Northern Regional...", and the only contributor was "Francine" (talk))
13:36, 24 June 2024 Francine talk contribs deleted page Data Dictionary: DRG Romania (content was: "{{forresearchers}} Go back to Database: Diagnosis Related Group (DRG) (Romania) page Source: [https://www.drg.ro/index.php?p=colaborare&s=model_analiza Click here to learn more] '''Indicators of clinical activity''' {| class="wikitable" ! Category ! Indicator |- | General indicators of activity volume and intensity | Number of cases |- | | Number of days of hospitalization |- | | Average duration of hospitalization |- | | Number of weighted cases |- | | Case complexi...")
13:11, 24 June 2024 Victor talk contribs deleted page Kortrijk Cancer Centre AZ Groeninge Trials (content was: "{{forpatients}} {{forresearchers}} Go back to Kortrijk Cancer Centre AZ Groeninge page '''NCTID''': NCT01332968 '''Title''': A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) '''Study Summary''': This open-label, randomized study will assess the efficacy and safety of obinutuzumab (RO5072759) in...")
13:11, 24 June 2024 Victor talk contribs deleted page Karolinska Institute and University Hospital Trials (content was: "'''NCTID''': NCT01360554 '''Title''': ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer '''Study Summary''': This is a multinational, multicenter, randomized,double-blinded, Phase 3 study comparing the efficacy and safety of treatment with PF-00299804 to treatment with erlotinib in patients with advance...", and the only contributor was "Woloski" (talk))
13:11, 24 June 2024 Victor talk contribs deleted page KCE Guidelines (Belgium) (content was: "{{forproviders}} Go back to Belgium page '''Primary purpose:''' Provides evidence-based recommendations for management, diagnosing, treating, and following up of many types of cancer. '''Sponsor, manager or home institution:''' dataOwner::Federaal Kenniscentrum voor de Gezondheidszorg. '''Type of information:''' availableVariable::cancer incidence, availableVariable::cancer survival, availableVariable::medical procedures for treatment and follow up of man...")
13:11, 24 June 2024 Victor talk contribs deleted page Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico Trials (content was: "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages....", and the only contributor was "Woloski" (talk))
13:11, 24 June 2024 Victor talk contribs deleted page Istituto Oncologico Veneto IRCCS-IOV Trials (content was: "'''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard...", and the only contributor was "Woloski" (talk))
13:11, 24 June 2024 Victor talk contribs deleted page Istituto Nazionale Tumori Regina Elena & Istituto Dermatologico San Gallicano Trials (content was: "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages....", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Istituto Nazionale Tumori -IRCCS 'Fondazione G.Pascale' Trials (content was: "'''NCTID''': NCT03771456 '''Title''': Anastomotic Leakage and Enhanced Recovery Pathways After Colorectal Surgery '''Study Summary''': Prospective observational multicenter study on the influence of adherence to enhanced recovery pathways on early outcomes (anastomotic leakage, morbidity, mortality, readmission, reoperation rates and length of postoperative stay) after ele...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Investigation: Investigation Project (Instituto Português de Oncologia de Coimbra Francisco Gentil) (content was: "{{forproviders}} {{forresearchers}} Go back to Instituto Português de Oncologia de Coimbra Francisco Gentil page '''Primary purpose:''' To explore, analyze, and gather information about a specific topic, issue, or problem in order to generate insights, make informed decisions, develop solutions, and contribute to knowledge or innovation within a particular field or co...", and the only contributor was "Francine" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Instituto Português de Oncologia do Porto Francisco Gentil Trials (content was: "'''NCTID''': NCT02500043 '''Title''': Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer '''Study Summary''': The purpose of this trial is to compare the effects of TAS-102 and best supportive care (BSC) with Placebo (an inactive drug) and best supportive care on metastatic gastric cancer. '''Sponsor''': Taiho Oncology, Inc. '''Intervention...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Instituto Português de Oncologia de Lisboa Francisco Gentil Trials (content was: "'''NCTID''': NCT04410445 '''Title''': Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence '''Study Summary''': The main purpose of this study is to compare the efficacy of bempegaldesleukin plus nivolumab versus nivolumab in patients with completel...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Instituto Português de Oncologia de Coimbra Francisco Gentil Trials (content was: "'''NCTID''': NCT04459715 '''Title''': A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) '''Study Summary''': The primary objective of the study is...", and the only contributor was "Woloski" (talk))
13:10, 24 June 2024 Victor talk contribs deleted page Echantillon généraliste de bénéficiaires (EGB) (content was: "[https://pubmed.ncbi.nlm.nih.gov/28544284/ [1]] '''Sponsor, manager or home institution:''' [https://assurance-maladie.ameli.fr/ Caisse Nationale de l'Assurance Maladie (CNAM)] '''Type of information:''' Identical to SNIIRAM, but on a smaller scale to be more manageable. Data structure is streamlined and simplified in the EGB. '''Source of Information:''' Includes data from...", and the only contributor was "Larysse" (talk))
12:47, 24 June 2024 Francine talk contribs deleted page Cancer areas of interest - DRG Romania (content was: "Go back to Romania page Source: [http://drg.ro/DocDRG/Lista_tabelara_a_diagnosticelor_RODRGv1.pdf] {| class="wikitable" |- ! Description || ICD code |- | Malignant tumors of the lip, oral cavity and pharynx || C00–C14 |- | Malignant tumors of esophagus || C15 |- | Malignant tumors of the stomach || C16 |- | Malignant tumors of the colon || C18 |- | Malignant tumor of the junction recto-sigmoid, rectum, anus and anal canal || C19–C21 |- | Malignant tumor of the liver...")
12:41, 24 June 2024 Francine talk contribs moved page Available type of information - DRG Romania to Available Data Dictionary - DRG Romania
02:08, 23 June 2024 Victor talk contribs deleted page Institute of Oncology Ljubljana Trials (content was: "'''NCTID''': NCT06060990 '''Title''': Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers '''Study Summary''': The aim of the study is to determine the total concentration of selected trace elements (Cu, Zn, Fe), the proportion of free Cu and Cu bound to ceruloplasmin and the isotopic ratio of Cu65/Cu63 in blood serum...", and the only contributor was "Woloski" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institut du Cancer de Montpellier Trials (content was: "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut du Cancer de Montpellier page '''NCTID''': NCT00875667 '''Title''': A Study to Determine the Efficacy of Lenalidomide Versus Investigator’s Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL) '''Study Summary''': To evaluate the safety and efficacy of lenalidomide versus investigator choice in patients with relapsed or refractory mantle cell lymphoma. '''Sponsor''': Celgen...")
02:08, 23 June 2024 Victor talk contribs deleted page Institut de Cancérologie de l'Ouest (ICO) - Integrated Center for Oncology Trials (content was: "'''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine alone, in patients with metastatic Pancreatic Ducta...", and the only contributor was "Woloski" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institut Sainte Catherine Trials (content was: "'''NCTID''': NCT01300143 '''Title''': Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma '''Study Summary''': Indication : Hepatocellular carcinoma, maximum size 9 cm, with single or multiple nodes whose total tumor mass can technically be irradiated, non-resectable, and no...", and the only contributor was "Woloski" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institut Paoli-Calmettes Trials (content was: "'''NCTID''': NCT04070443 '''Title''': Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase '''Study Summary''': The investigators hypothesize that, in newly diagnosed de novo chronic phase CML patients, an induction treatment with ponatinib for 6 months should increase the rate of patients reaching a stable MR...", and the only contributor was "Woloski" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institut Jules Bordet Trials (content was: "{{forpatients}} {{forresearchers}} Go back to Institut Jules Bordet page '''NCTID''': NCT04966715 '''Title''': Inferior Epigastric Lymph Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Colorectal Peritoneal Metastases '''Study Summary''': In this study, the investigators propose to systematically collect and analyse epigastric lymph nodes during complete cytureductive surgery in patients with colorectal carcinomatosis, in order to define their role in the...")
02:08, 23 June 2024 Victor talk contribs deleted page Institut Godinot Trials (content was: "'''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine alone, in patients with metastatic Pancreatic Ducta...", and the only contributor was "Woloski" (talk))
02:08, 23 June 2024 Victor talk contribs deleted page Institut Curie Trials (content was: "'''NCTID''': NCT03875573 '''Title''': Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: '''Study Summary''': Neo-CheckRay is a multicenter, open-label phase II study that randomizes luminal B breast cancer subjects candidate for neo-adjuvant chemotherapy in a 1:1:1 ratio in 3...", and the only contributor was "Woloski" (talk))
02:07, 23 June 2024 Victor talk contribs deleted page Infant deaths occurring in the EU by cause and age (content was: "Go back to European Union - wide Resources page '''Type of Information:''' Infant mortality rate; Year; Sex; ICD-10; Age class. '''Source of Information:''' The specific sources vary by country. '''Data level:''' EU level. '''Number of Records:''' Unknown. '''Date Range:''' 2011-2020. '''Cancer Areas of Interest:''' Neoplasms (C00-D48). '''Open data access:''' P...", and the only contributor was "Francine" (talk))
02:07, 23 June 2024 Victor talk contribs deleted page Hospital admission with diagnoses and procedures related (content was: "===Databases=== *SNIIRAM *Echantillon généraliste de bénéficiaires (EGB) *PMSI", and the only contributor was "Larysse" (talk))
02:07, 23 June 2024 Victor talk contribs deleted page Health care expenses and reimbursement (content was: "===Databases=== *SNIIRAM *Echantillon généraliste de bénéficiaires (EGB) *Open Damir: Complete Database on Health Insurance Expenditure *National data on health insurance expenditure for community care", and the only contributor was "Larysse" (talk))
02:07, 23 June 2024 Victor talk contribs deleted page Facility: Accommodation for families with children - Hjältarnas hus (University Hospital of Umeå - Norrland University Hospital) (content was: "Go back to University Hospital of Umeå - Norrland University Hospital page {{forpatients}} '''Primary purpose:''' To provide temporary accommodations for families with children affected by long-term illnesses, facilitating their stay through bookings from attending physicians or department heads. '''Cancer areas of interest:''' hasCancerType::C00-D48: All neoplasms. '''Access to information:''' [https://hjaltarnashus.se/ Click here to learn more].")
02:07, 23 June 2024 Victor talk contribs deleted page Administrative or Claims Data (content was: "'''[This page is empty. Information will be added soon.]'''", and the only contributor was "Lucas" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page IRCCS Ospedale Policlinico San Martino Trials (content was: "'''NCTID''': NCT05291156 '''Title''': CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy '''Study Summary''': This is a non-profit phase II, randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy, compared to cetuximab alone, in pre-treated RAS/BRAF wild type metastatic colorect...", and the only contributor was "Woloski" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page IRCCS Centro di Riferimento Oncologico della Basilicata Trials (content was: "'''NCTID''': NCT03268954 '''Title''': Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) '''Study Summary''': The purpose of this study is to determine whether the combination of pevon...", and the only contributor was "Woloski" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page IRCCS - Romagna Institute for the Study of Cancer 'Dino Amadori' Trials (content was: "'''NCTID''': NCT04775290 '''Title''': Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy '''Study Summary''': The study aims to investigate, through serial measurements of some biomarkers, the potential mechanisms through which yoga impacts on QOL and fatigue. '''Sponsor''': Istituto Scientifico Romagnolo per lo...", and the only contributor was "Woloski" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page Humanitas Research Hospital Trials (content was: "'''NCTID''': NCT04800497 '''Title''': The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC '''Study Summary''': Hepatocellular carcinoma (HCC) recurs in up to 60% of patients who undergo resection. Circulating tumor cells (CTC) have been advocated as promotors of the recurrence. However, their role as prognostic markers in the surgical se...", and the only contributor was "Woloski" (talk))
02:06, 23 June 2024 Victor talk contribs deleted page Here. (content was: "{| class="wikitable" ! Section !! Tags !! Definition |- | Healthcare System || hasHealthcareSystem:: || Identifies a country page has a description of its healthcare system |- | Administrative or Claims Data || hasDatabase:: || Identifies a country page has link to a database wiki page |- | Registries || hasDatabase:: || Identifies a country page has link to a database wiki...", and the only contributor was "Francine" (talk))